Form 8-K - Current report:
SEC Accession No. 0001193125-25-022242
Filing Date
2025-02-07
Accepted
2025-02-07 06:35:20
Documents
16
Period of Report
2025-02-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d931211d8k.htm   iXBRL 8-K 36554
2 EX-10.1 d931211dex101.htm EX-10.1 142077
3 EX-99.1 d931211dex991.htm EX-99.1 8705
7 GRAPHIC g931211g0207055812383.jpg GRAPHIC 4679
  Complete submission text file 0001193125-25-022242.txt   346893

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gh-20250206.xsd EX-101.SCH 2853
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gh-20250206_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gh-20250206_pre.xml EX-101.PRE 10816
18 EXTRACTED XBRL INSTANCE DOCUMENT d931211d8k_htm.xml XML 3496
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 25599212
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)